Implantable Capsule Shows Promise For Alzheimer’s Prevention, EPFL Study

There is currently no way to prevent or slow Alzheimer’s disease, but a new study details the creation of an implantable capsule that researchers say could stop the condition in its tracks.

In the journal Brain, researchers from the École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland reveal how, when implanted under the skin, the capsule releases antibodies that travel to the brain and trigger the patient’s immune system to clear beta-amyloid protein.

Beta-amyloid protein is believed to be a key player in the development of Alzheimer’s disease. The protein clumps together in the brain, forming plaques that accumulate in the spaces between nerve cells, which researchers suggest interfere with the processes these cells need to survive.

MORE ON THIS TOPIC